Literature DB >> 16361697

Utilization of substrate-induced quenching for screening targets promoting NADH and NADPH consumption.

María Jesús Vázquez1, Stephen Ashman, Fernando Ramón, David Calvo, Ana Bardera, J Julio Martín, Martin Rüdiger, David Tew, Juan Manuel Domínguez.   

Abstract

Oxidation of reduced nicotinamide adenine dinucleotides is a common event for many biochemical reactions. However, its exploitation for ultrahigh-throughput screening purposes is not an easy task and is affected by various drawbacks. It is known that such nucleotides induce quenching on the fluorescence of several dyes and that this quenching disappears with oxidation of the nucleotide. We have made use of this property to develop an assay for high-throughput screening with NADH and NADPH-dependent reductases. Full screening campaigns have been run with excellent assay quality parameters, and interesting hits have been identified. The method is amenable to miniaturization and allows easy identification of false positives without needing extra secondary assays. Although it is based on monitoring substrate consumption, it is demonstrated that the effect of fractional conversion on assay sensitivity is negligible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16361697     DOI: 10.1177/1087057105283296

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  1 in total

1.  Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor.

Authors:  María Martínez-Hoyos; Esther Perez-Herran; Gulcin Gulten; Lourdes Encinas; Daniel Álvarez-Gómez; Emilio Alvarez; Santiago Ferrer-Bazaga; Adolfo García-Pérez; Fátima Ortega; Iñigo Angulo-Barturen; Joaquin Rullas-Trincado; Delia Blanco Ruano; Pedro Torres; Pablo Castañeda; Sophie Huss; Raquel Fernández Menéndez; Silvia González Del Valle; Lluis Ballell; David Barros; Sundip Modha; Neeraj Dhar; François Signorino-Gelo; John D McKinney; Jose Francisco García-Bustos; Jose Luis Lavandera; James C Sacchettini; M Soledad Jimenez; Nuria Martín-Casabona; Julia Castro-Pichel; Alfonso Mendoza-Losana
Journal:  EBioMedicine       Date:  2016-05-08       Impact factor: 8.143

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.